Literature DB >> 29455516

Core-Shell Microneedle Gel for Self-Regulated Insulin Delivery.

Jinqiang Wang1,2, Yanqi Ye1,2, Jicheng Yu1,2, Anna R Kahkoska3, Xudong Zhang1,2, Chao Wang1,2, Wujin Sun1,2, Ria D Corder4, Zhaowei Chen1,2, Saad A Khan4, John B Buse3, Zhen Gu1,2,3.   

Abstract

A bioinspired glucose-responsive insulin delivery system for self-regulation of blood glucose levels is desirable for improving health and quality of life outcomes for patients with type 1 and advanced type 2 diabetes. Here we describe a painless core-shell microneedle array patch consisting of degradable cross-linked gel for smart insulin delivery with rapid responsiveness and excellent biocompatibility. This gel-based device can partially dissociate and subsequently release insulin when triggered by hydrogen peroxide (H2O2) generated during the oxidation of glucose by a glucose-specific enzyme covalently attached inside the gel. Importantly, the H2O2-responsive microneedles are coated with a thin-layer embedding H2O2-scavenging enzyme, thus mimicking the complementary function of enzymes in peroxisomes to protect normal tissues from injury caused by oxidative stress. Utilizing a chemically induced type 1 diabetic mouse model, we demonstrated that this smart insulin patch with a bioresponsive core and protective shell could effectively regulate the blood glucose levels within a normal range with improved biocompatibility.

Entities:  

Keywords:  diabetes; drug delivery; hydrogel; microneedle; stimuli-responsive

Mesh:

Substances:

Year:  2018        PMID: 29455516      PMCID: PMC6037424          DOI: 10.1021/acsnano.7b08152

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  36 in total

1.  Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery.

Authors:  Jicheng Yu; Yuqi Zhang; Yanqi Ye; Rocco DiSanto; Wujin Sun; Davis Ranson; Frances S Ligler; John B Buse; Zhen Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

2.  Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery.

Authors:  Zhen Gu; Tram T Dang; Minglin Ma; Benjamin C Tang; Hao Cheng; Shan Jiang; Yizhou Dong; Yunlong Zhang; Daniel G Anderson
Journal:  ACS Nano       Date:  2013-07-08       Impact factor: 15.881

3.  Biomimetic enzyme nanocomplexes and their use as antidotes and preventive measures for alcohol intoxication.

Authors:  Yang Liu; Juanjuan Du; Ming Yan; Mo Yin Lau; Jay Hu; Hui Han; Otto O Yang; Sheng Liang; Wei Wei; Hui Wang; Jianmin Li; Xinyuan Zhu; Linqi Shi; Wei Chen; Cheng Ji; Yunfeng Lu
Journal:  Nat Nanotechnol       Date:  2013-02-17       Impact factor: 39.213

Review 4.  Managing diabetes with nanomedicine: challenges and opportunities.

Authors:  Omid Veiseh; Benjamin C Tang; Kathryn A Whitehead; Daniel G Anderson; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2014-11-28       Impact factor: 84.694

5.  Glucose-responsive insulin by molecular and physical design.

Authors:  Naveed A Bakh; Abel B Cortinas; Michael A Weiss; Robert S Langer; Daniel G Anderson; Zhen Gu; Sanjoy Dutta; Michael S Strano
Journal:  Nat Chem       Date:  2017-09-22       Impact factor: 24.427

6.  Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates.

Authors:  Danny Hung-Chieh Chou; Matthew J Webber; Benjamin C Tang; Amy B Lin; Lavanya S Thapa; David Deng; Jonathan V Truong; Abel B Cortinas; Robert Langer; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

7.  Glucose-responsive polymer gel bearing phenylborate derivative as a glucose-sensing moiety operating at the physiological pH.

Authors:  Akira Matsumoto; Ryo Yoshida; Kazunori Kataoka
Journal:  Biomacromolecules       Date:  2004 May-Jun       Impact factor: 6.988

8.  Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

Authors:  Y Ohkubo; H Kishikawa; E Araki; T Miyata; S Isami; S Motoyoshi; Y Kojima; N Furuyoshi; M Shichiri
Journal:  Diabetes Res Clin Pract       Date:  1995-05       Impact factor: 5.602

Review 9.  Emerging micro- and nanotechnology based synthetic approaches for insulin delivery.

Authors:  Ran Mo; Tianyue Jiang; Jin Di; Wanyi Tai; Zhen Gu
Journal:  Chem Soc Rev       Date:  2014-03-14       Impact factor: 54.564

10.  Fusogenic Reactive Oxygen Species Triggered Charge-Reversal Vector for Effective Gene Delivery.

Authors:  Xin Liu; Jiajia Xiang; Dingcheng Zhu; Liming Jiang; Zhuxian Zhou; Jianbin Tang; Xiangrui Liu; Yongzhuo Huang; Youqing Shen
Journal:  Adv Mater       Date:  2015-12-14       Impact factor: 30.849

View more
  28 in total

Review 1.  Glucose-Responsive Insulin and Delivery Systems: Innovation and Translation.

Authors:  Jinqiang Wang; Zejun Wang; Jicheng Yu; Anna R Kahkoska; John B Buse; Zhen Gu
Journal:  Adv Mater       Date:  2019-08-18       Impact factor: 30.849

Review 2.  Glucose-Responsive Microneedle Patches for Diabetes Treatment.

Authors:  Guojun Chen; Jicheng Yu; Zhen Gu
Journal:  J Diabetes Sci Technol       Date:  2018-05-31

3.  Bioinspired and Biomimetic Nanomedicines.

Authors:  Zhaowei Chen; Zejun Wang; Zhen Gu
Journal:  Acc Chem Res       Date:  2019-04-12       Impact factor: 22.384

4.  A forskolin-conjugated insulin analog targeting endogenous glucose-transporter for glucose-responsive insulin delivery.

Authors:  Jinqiang Wang; Zejun Wang; Jicheng Yu; Yuqi Zhang; Yi Zeng; Zhen Gu
Journal:  Biomater Sci       Date:  2019-10-14       Impact factor: 6.843

5.  Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery.

Authors:  Jinqiang Wang; Zejun Wang; Guojun Chen; Yanfang Wang; Tianyuan Ci; Hongjun Li; Xiangsheng Liu; Daojia Zhou; Anna R Kahkoska; Zhuxian Zhou; Huan Meng; John B Buse; Zhen Gu
Journal:  ACS Nano       Date:  2021-03-08       Impact factor: 15.881

Review 6.  Microneedles for transdermal diagnostics: Recent advances and new horizons.

Authors:  Gui-Shi Liu; Yifei Kong; Yensheng Wang; Yunhan Luo; Xudong Fan; Xi Xie; Bo-Ru Yang; Mei X Wu
Journal:  Biomaterials       Date:  2019-12-26       Impact factor: 12.479

Review 7.  Advances in transdermal insulin delivery.

Authors:  Yuqi Zhang; Jicheng Yu; Anna R Kahkoska; Jinqiang Wang; John B Buse; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-12-08       Impact factor: 15.470

8.  Glucose transporter inhibitor-conjugated insulin mitigates hypoglycemia.

Authors:  Jinqiang Wang; Jicheng Yu; Yuqi Zhang; Anna R Kahkoska; Zejun Wang; Jun Fang; Julian P Whitelegge; Song Li; John B Buse; Zhen Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-16       Impact factor: 11.205

Review 9.  Drug Delivery Strategies for the Treatment of Metabolic Diseases.

Authors:  Sanjun Shi; Na Kong; Chan Feng; Aram Shajii; Claire Bejgrowicz; Wei Tao; Omid C Farokhzad
Journal:  Adv Healthc Mater       Date:  2019-04-08       Impact factor: 9.933

Review 10.  An update on microneedle-based systems for diabetes.

Authors:  Wen Xuan Li; Xiao Peng Zhang; Bo Zhi Chen; Wen Min Fei; Yong Cui; Can Yang Zhang; Xin Dong Guo
Journal:  Drug Deliv Transl Res       Date:  2022-02-02       Impact factor: 5.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.